When a pharmacy closes, 89% would stay with the same chain, and an on-time guarantee holds them better than a discount
89% of US pharmacy users (178 of 200) would keep their prescriptions with the same chain when their store closes, and a guarantee the prescription is ready on time is the strongest thing that holds them (75.5%), while a discount is the weakest (36.5%), September 2026.
- Who was asked
- US adults who use a pharmacy, 200 clones, US
- When
- September 2026 (fielded 28 September 2026)
- How
- Predicted responses from Brox clones, each built from a long-form interview with a real person.
- What changed from the obvious question
- The obvious question is whether people would leave. That is answered in one line, so the study spent most of its questions on the five things a chain could offer instead, which is the part a decision actually rests on.
Section 01: What the panel said
- #
89%
A store closing moves almost nobody off the chain: 89% (178 of 200) would keep their prescriptions with it.
base 200
- #
75.5%
The strongest thing the chain can offer is an operational promise, not a discount.
base 200
- #
54%
What worries them is supply: delay outranks cost surprises six to one.
base 200
- #
7
The few who would move away are the ones an automatic transfer does not satisfy: 7 of the 22 react negatively to it, against 8 of the 178 who would stay.
base 22 · contrast
The strongest thing the chain can offer is an operational promise, not a discount.
02What is the first thing to take from this?
A pharmacy closing is not, by itself, where a chain loses the prescription. Asked where they would move it if the store they use shut for good, 89% (178 of 200) stayed inside the same chain: 131 would go to the nearest branch and 47 would use the chain's own mail service. Only 14 named a rival retail chain, and 6 an independent pharmacy or a provider's own.
That holds across every age band we can cut, from 33 of 33 under thirties to 58 of 70 among the 45 to 64s, so it is not one group carrying the result. The caution is in the method rather than the spread, and it is a real one: none of these people is actually facing a closure, so 89% is a ceiling on what a chain can hope to keep, not a forecast of what it will.
03What actually holds somebody, and what does not?
Five things a chain could offer were tested on the same 200 people. A guarantee that the prescription will be ready on time is the strongest by a distance: 75.5% said it would be very likely to keep them. Free shipping from a central fulfillment center follows on 63.5%, then staff help to move the prescription on 59.5%, then an automatic transfer to the nearest branch on 50.5%.
A discount or rewards offer came last, on 36.5%. It is the lever a retailer reaches for first and the one this panel rates lowest, 39 points behind an operational promise that costs nothing to state.
04What are people actually afraid of?
Supply, not price. Asked what would worry them most about staying with the chain after their store closed, 54% (108 of 200) named delays in getting their medication. Losing access to a pharmacist came second on 12.5% (25), and cost surprises third on 9% (18), so delay outranks money six to one.
The worry and the remedy are the same axis, which is why the on-time guarantee tops the list. It is the only offer that speaks to the thing people say they are frightened of.
05Who are the few who would leave?
Twenty-two of the 200 would move away from the chain. That is a small base and the figures below are counts for that reason, but the group is coherent. They are the people an automatic transfer does not satisfy: 7 of the 22 react negatively to having their prescriptions moved to the nearest branch for them, against 8 of the 178 who would stay. They are also roughly twice as likely to name losing their pharmacist as their main worry, 5 of 22 against 19 of 178.
So the default remedy and the leavers are not the same conversation. An automatic transfer keeps the people who were going to stay anyway, and is close to the reason the rest give for going.
06What would a customer team do with this?
- A reading, not the panel's answer: if the on-time promise is the strongest lever and delay is the biggest fear, the closure communication is an operations message rather than a marketing one, and the discount budget is arguably the wrong instrument.
- A second reading: the small group who reject the automatic transfer are worth a different treatment, because being moved without being asked is close to what they object to.
- What would settle it: the same questions put to people who have actually had a pharmacy close, where the answer is recalled rather than imagined.
Section 07: What they said, and the interview line it rests on
“My main worry would be prescription access delays and actually getting my medications on time. I have diabetes and other pre-existing conditions, and I take essential medications that I cannot go without.”
Predicted from this line in the interview
“If it's something absolutely essential like I'm on certain medications, I will die if I don't have.”
Section 08: How much should you trust this?
What we would defend
- A store closing moves almost nobody off the chain: 89% (178 of 200) would keep their prescriptions with it.
- The strongest thing the chain can offer is an operational promise, not a discount.
- What worries them is supply: delay outranks cost surprises six to one.
What we would not
- The group who would move away is a base of 22 and is reported as counts: the direction is clear, the size is not.
- 91% gave convenience as the main reason for their choice, a concentration high enough that the answer list may have done more work than the respondents did, so read the ranking of levers rather than that figure.
The main limitation
Nobody on the panel was actually facing a closure: the screener qualified 0 of 779, so every figure is stated intent about a hypothetical and 89% is a ceiling rather than a forecast.
Section 09: How was this run?
| Segment | Clones |
|---|---|
| Stay with the chain | 178 |
| Move to another pharmacy | 22 |
Question wording as fielded
- Do you currently have one or more prescriptions filled at a pharmacy store that is closing or has recently been told it will close?
- What would be the main reason for that choice?
- If the chain automatically moved your prescriptions to the nearest branch of the same chain, how would you feel about using that location instead?
- Which of these options from the same pharmacy chain would make you keep your prescriptions with them after your store closes?
- What would worry you most about keeping your prescriptions with the same pharmacy chain after your store closes?
- Thinking about the following options, how likely would each one be to keep you with the same pharmacy chain after your store closes?
- If the same pharmacy chain offered free shipping of your prescriptions from its central fulfilment centre, how likely would you be to keep your prescriptions with the chain that way?
- If your usual pharmacy store closes for good, where would you most likely move your prescriptions?
- Which of the following pharmacy options would you seriously consider after your store closes?
What was not asked, and why
Nobody was asked what they actually did when a pharmacy closed. The screener looked for people whose store is closing and qualified none of 779, so every answer here is stated intent about a hypothetical closure rather than recalled behavior.
What changed from the obvious question
The obvious question is whether people would leave. That is answered in one line, so the study spent most of its questions on the five things a chain could offer instead, which is the part a decision actually rests on.
Fielded through Ask Brox on 28 September 2026.
More on Why patients stay on a medicine, and why they stop · Pharma & HCP · Healthcare (US) panel
Ask this of your own customers: humans@brox.ai
Related insights
All in this topic-
Patient adherence breaks at the copay: 48.5% would stop a daily blood pressure pill when it jumps from $15 to $60 a month
48.5% 48.5% would stop the blood pressure pill once its copay rose from $15 to $60 a month, on top of no felt benefit and afternoon tiredness, up from 14.0% with the tiredness alone and 1.5% with no felt benefit alone. (base 200)
Read -
Antidepressant cost: only 35.0% of US adults prescribed one for depression would stay on it at $150 a month, against 82.2% at $50
35% 35.0% would stay on an antidepressant that is helping at $150 a month, against 82.2% at $50 and 97.0% at $10; no clone rates itself more likely to stay on at a higher price. (base 197)
Read -
Seeing it work keeps US adults on a statin they cannot feel: a cholesterol test result wins over 92.2% of those not yet certain, home delivery 27.5%, and a $30 a month rise is the top reason to stop below $50,000 a year
98% A follow-up blood test showing cholesterol down by a third lifts the share of US adults very likely to still be taking a daily statin a year later from 74.5% to 98.0%; automatic home delivery every three months at the same $10 a month lifts it to 80.5%. Every case had no side effects and no change in how the person feels. (base 200)
Read -
Side-effect fears hold back 67.0% of US adults from a recommended statin, and a test of their own heart risk, not a lower price, is what would change their minds
67% 67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost. (base 200)
Read